Iago Pinal-Fernandez
Affiliations: | National Institutes of Health,Bethesda |
Area:
Myositis, Dermatomyositis, Polymyositis, Inclusion Body Myositis, Myopathies, Methodology, Statistics, Bioinformatics, EpidemiologyGoogle:
"Iago Pinal-Fernandez"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Torres-Ruiz J, Pinal-Fernandez I, Selva-O'Callaghan A, et al. (2024) Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 42: 367-376 |
| Kleefeld F, Horvath R, Pinal-Fernandez I, et al. (2024) Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2. Acta Neuropathologica. 147: 19 |
| Lloyd TE, Michelle EH, Pinal-Fernandez I, et al. (2023) Author Response: Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis. Neurology. 101: 500 |
| Muñoz-Braceras S, Pinal-Fernandez I, Casal-Dominguez M, et al. (2023) Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy. Cells. 12 |
| Pinal-Fernandez I, Milisenda JC, Pak K, et al. (2023) Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Annals of the Rheumatic Diseases |
| Sherman MA, Pak K, Pinal-Fernandez I, et al. (2023) Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis. Arthritis & Rheumatology (Hoboken, N.J.) |
| Mammen AL, Amato AA, Dimachkie MM, et al. (2023) Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. Rheumatology. 5: e67-e76 |
| Pinal-Fernandez I, Quintana A, Milisenda JC, et al. (2023) Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Annals of the Rheumatic Diseases |
| Nascimento A, Bruels CC, Donkervoort S, et al. (2023) Variants in DTNA cause a mild, dominantly inherited muscular dystrophy. Acta Neuropathologica |
| Casal-Dominguez M, Pinal-Fernandez I, Pak K, et al. (2023) Coordinated local RNA overexpression of complement induced by interferon gamma in myositis. Scientific Reports. 13: 2038 |